XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net income $ 26,478 $ 14,161
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation 17,152 14,128
Amortization of intangible assets 24,750 25,823
Amortization of original issue discount and deferred financing costs 973 954
Change in fair value of investment 6,019 0
Deferred income taxes (5,405) (10,712)
Share-based compensation expense [1] 12,440 10,334
(Gain) loss on disposal of assets (52) 30
Other noncash charges 1,410 (160)
Excess tax expense (benefits) from equity awards 1,009 (998)
Net changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 13,664 33,925
Inventories (18,109) (23,820)
Other assets (920) (5,576)
Accounts payable 44,682 (24,488)
Accrued wages and employee benefits (8,512) 1,630
Other accrued liabilities (3,681) (53,790)
Net cash provided by (used in) operating activities 111,898 (18,559)
Investing activities    
Proceeds from sale of property and equipment 51 84
Proceeds from beneficial interests in securitization transactions 0 795
Contribution to tax equity investment (1,629) 0
Net proceeds from (purchase of) long-term investment 1,761 (2,000)
Expenditures for property and equipment (26,820) (23,977)
Acquisition of business, net of cash acquired 0 (16,188)
Net cash used in investing activities (26,637) (41,286)
Financing activities    
Proceeds from short-term borrowings 8,970 19,515
Proceeds from long-term borrowings 471 267,869
Repayments of short-term borrowings (18,489) (5,080)
Repayments of long-term borrowings and finance lease obligations (7,030) (113,573)
Payment of contingent acquisition consideration 0 (479)
Payment of deferred acquisition consideration (6,000) 0
Payment for additional ownership interest (9,117) (104,844)
Taxes paid related to equity awards (5,455) (4,710)
Proceeds from exercise of stock options 319 4,975
Net cash (used in) provided by financing activities (36,331) 63,673
Effect of exchange rate changes on cash and cash equivalents (569) 814
Net increase in cash and cash equivalents 48,361 4,642
Cash and cash equivalents at beginning of period 200,994 132,723
Cash and cash equivalents at end of period $ 249,355 $ 137,365
[1] Represents share-based compensation expense to account for stock options, restricted stock and other stock awards over their respective vesting periods.